Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Surfactant protein C mutation links postnatal type 2 cell dysfunction to adult disease
Sneha Sitaraman, … , Yan Xu, Timothy E. Weaver
Sneha Sitaraman, … , Yan Xu, Timothy E. Weaver
Published June 17, 2021
Citation Information: JCI Insight. 2021;6(14):e142501. https://doi.org/10.1172/jci.insight.142501.
View: Text | PDF
Research Article Cell biology Pulmonology

Surfactant protein C mutation links postnatal type 2 cell dysfunction to adult disease

  • Text
  • PDF
Abstract

Mutations in the gene SFTPC, encoding surfactant protein C (SP-C), are associated with interstitial lung disease in children and adults. To assess the natural history of disease, we knocked in a familial, disease-associated SFTPC mutation, L188Q (L184Q [LQ] in mice), into the mouse Sftpc locus. Translation of the mutant proprotein, proSP-CLQ, exceeded that of proSP-CWT in neonatal alveolar type 2 epithelial cells (AT2 cells) and was associated with transient activation of oxidative stress and apoptosis, leading to impaired expansion of AT2 cells during postnatal alveolarization. Differentiation of AT2 to AT1 cells was also inhibited in ex vivo organoid culture of AT2 cells isolated from LQ mice; importantly, treatment with antioxidant promoted alveolar differentiation. Upon completion of alveolarization, SftpcLQ expression was downregulated, leading to resolution of chronic stress responses; however, the failure to restore AT2 cell numbers resulted in a permanent loss of AT2 cells that was linked to decreased regenerative capacity in the adult lung. Collectively, these data support the hypothesis that susceptibility to disease in adult LQ mice is established during postnatal lung development, and they provide a potential explanation for the delayed onset of disease in patients with familial pulmonary fibrosis.

Authors

Sneha Sitaraman, Emily P. Martin, Cheng-Lun Na, Shuyang Zhao, Jenna Green, Hitesh Deshmukh, Anne-Karina T. Perl, James P. Bridges, Yan Xu, Timothy E. Weaver

×

Figure 5

Oxidative stress is associated with proapoptotic signaling and impaired differentiation.

Options: View larger image (or click on image) Download as PowerPoint
Oxidative stress is associated with proapoptotic signaling and impaired ...
(A) Relative Bax mRNA levels in isolated AT2 cells obtained by quantitative PCR of 25 ng of cDNA. Data were normalized to Ppia expression. (B) Western blotting for proapoptotic protein, BAX. In total, 30 μg of AT2 cell lysates was separated by SDS-PAGE. (C) Densitometry for BAX levels in B. Data were normalized to Actin. (D) Confocal images of organoids generated from P4 WT and LQ/LQ AT2 cells. Organoid cultures were treated with or without the antioxidant, butylated hydroxyanisole (BHA). HOPX, AT1 cell marker; CCSP, club cell (proximal airway epithelial cell) marker; α-SMA: α-smooth muscle actin; proSP-C, AT2 cell marker; ECAD, pan-epithelial cell marker; AGER, AT1 cell marker. Scale bars: 100 μm. (E–H) Morphometric analyses of HOPX+ (E), AGER+ (F), proSP-C+ (G), and CCSP+ (H) organoids (circles, WT; squares, LQ/LQ). For A, C, and E–H, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by 2-way ANOVA with Sidak’s multiple comparison test. Unedited blots are available online with this article.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts